DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04259138 (ClinicalTrials.gov)	September 17, 2020	4/2/2020	Determination of the Optimal Treatment Target in Ulcerative Colitis	VERDICT: In actiVE Ulcerative Colitis, a RanDomIzed Controlled Trial for Determination of the Optimal Treatment Target	Colitis, Ulcerative	Biological: Treatment Algorithm A;Biological: Treatment Algorithm B;Biological: Treatment Algorithm C	Robarts Clinical Trials Inc.	Takeda Development Center Americas, Inc.	Recruiting	18 Years	N/A	All	660	Phase 4	United States;Canada

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

September 17, 2020

4/2/2020

Determination of the Optimal Treatment Target in Ulcerative Colitis

VERDICT: In actiVE Ulcerative Colitis, a RanDomIzed Controlled Trial for Determination of the Optimal Treatment Target

Colitis, Ulcerative

Biological: Treatment Algorithm A;Biological: Treatment Algorithm B;Biological: Treatment Algorithm C

Robarts Clinical Trials Inc.

Takeda Development Center Americas, Inc.

Recruiting

18 Years

N/A

All

660

Phase 4

United States;Canada